Close Menu
Home › FDA Commissioner, Personalized Medicine Proponent Scott Gottlieb Resigns

FDA Commissioner, Personalized Medicine Proponent Scott Gottlieb Resigns

Mar 05, 2019
|
staff reporter

NEW YORK (GenomeWeb) – FDA Commissioner and personalized medicine champion Scott Gottlieb announced he will resign as the head of the agency in a month. 

In a letter to HHS Secretary Alex Azar, Gottlieb highlighted his efforts to modernize the development process for novel medical technologies, gene therapies, and targeted treatments as among his accomplishments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Featured Webinar

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
03
Featured Webinar

Streamlined and High-Precision Cancer Analysis Using an Automated NGS Workflow in the Reference Lab Setting

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
10
Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Molecular Diagnostics

  1. Natera Finds High Performance for Noninvasive Prenatal Test in All Age Groups

    Premium

  2. BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth

    Premium

  3. Exact Sciences Stock Falls on Publication of New CRC Screening Cost-Effectiveness Study

  4. OncoCyte Resurrecting Lung Cancer Assay Once Marketed by Life Technologies

    Premium

  5. Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.